Vanguard Group Inc. Has $173.36 Million Position in Trupanion, Inc. (NASDAQ:TRUP)

Vanguard Group Inc. boosted its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 1.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 3,596,725 shares of the financial services provider’s stock after purchasing an additional 45,653 shares during the period. Vanguard Group Inc. owned about 0.08% of Trupanion worth $173,362,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. SBI Securities Co. Ltd. acquired a new position in shares of Trupanion during the 4th quarter worth $25,000. Jones Financial Companies Lllp boosted its holdings in Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 238 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Trupanion during the third quarter worth $54,000. KBC Group NV bought a new position in Trupanion during the fourth quarter valued at about $75,000. Finally, R Squared Ltd acquired a new stake in shares of Trupanion in the fourth quarter worth about $79,000.

Insider Activity at Trupanion

In other Trupanion news, SVP Emily Dreyer sold 14,025 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the sale, the senior vice president now owns 27,645 shares in the company, valued at approximately $895,974.45. This trade represents a 33.66 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the sale, the chief executive officer now owns 118,784 shares in the company, valued at approximately $4,415,201.28. This represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 29,792 shares of company stock worth $989,442 in the last ninety days. 5.50% of the stock is currently owned by insiders.

Trupanion Price Performance

NASDAQ TRUP opened at $34.34 on Monday. The stock has a 50-day simple moving average of $39.64 and a 200 day simple moving average of $46.20. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The stock has a market capitalization of $1.46 billion, a PE ratio of -149.30, a P/E/G ratio of 6.02 and a beta of 1.66. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Research analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Stifel Nicolaus lowered their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler lowered their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.